Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D06IHB
|
|||
Drug Name |
PMID25435179-Compound-WO2012106509CAY10602
|
|||
Company |
THE TRUSTEES OF PRINCETON UNIVERSITY SHENK, Thomas KOYUNCU, Emre CRISTEA, Ileana
|
|||
Structure |
Download2D MOL |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | NAD-dependent deacetylase sirtuin-1 (SIRT1) | Target Info | Inhibitor | [1] |
Target's Patent Info | NAD-dependent deacetylase sirtuin-1 (SIRT1) | Target's Patent Info | [1] | |
KEGG Pathway | FoxO signaling pathway | |||
AMPK signaling pathway | ||||
Glucagon signaling pathway | ||||
Amphetamine addiction | ||||
MicroRNAs in cancer | ||||
Panther Pathway | p53 pathway | |||
Pathway Interaction Database | p73 transcription factor network | |||
Signaling events mediated by HDAC Class III | ||||
E2F transcription factor network | ||||
HIF-2-alpha transcription factor network | ||||
Signaling events mediated by HDAC Class I | ||||
FoxO family signaling | ||||
Regulation of Androgen receptor activity | ||||
Regulation of retinoblastoma protein | ||||
Reactome | RORA activates gene expression | |||
Regulation of HSF1-mediated heat shock response | ||||
Circadian Clock | ||||
WikiPathways | Integrated Pancreatic Cancer Pathway | |||
SREBF and miR33 in cholesterol and lipid homeostasis | ||||
Integrated Breast Cancer Pathway | ||||
SREBP signalling | ||||
Androgen receptor signaling pathway |
References | Top | |||
---|---|---|---|---|
REF 1 | Sirtuin modulators: an updated patent review (2012 - 2014).Expert Opin Ther Pat. 2015 Jan;25(1):5-15. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.